TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss by Caversaccio, Marco et al.
Eur Arch Otorhinolaryngol (2008) 265:1289–1292
DOI 10.1007/s00405-008-0610-3
CASE REPORT
TAP deWciency syndrome: chronic rhinosinusitis and conductive 
hearing loss
Marco Caversaccio · Harald Marcel Bonél · 
Rachel Carter · Anthony P. Williams · 
Stephan D. Gadola 
Received: 27 July 2007 / Accepted: 7 February 2008 / Published online: 19 February 2008
©  Springer-Verlag 2008
Abstract Nose–ear–throat manifestations of immunode-
Wciency disorders represent a diagnostic challenge for clini-
cians as these diseases often constitute the initial sign for
connective disorders or autoimmune disease. The history of
chronic rhinosinusitis and conductive hearing loss is often
non speciWc. Therefore attention to an HLA class I deW-
ciency must be considered if the disease has not been
diagnosed on routine examination. One of the syndromes is
due to a defective TAP complex, the peptide transporter
complex associated with antigen presentation. Herein, we
report two sisters with TAP-deWciency. The treatment of
choice for TAP-deWcient patients is conservative.
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Introduction
Human primary immunodeWciency syndromes (PID) in
adult patients often present the clinician with a diagnostic
challenge. The upper airways are commonly initially
involved in PID, but the history, clinical and histopatholo-
gical Wndings are usually non-speciWc. TAP-deWciency syn-
drome is a recently described human PID, which clinically
can resemble Wegener’s granulomatosis (WG). Early diag-
nosis of TAP-deWciency is important, since inappropriate
immunosuppressive treatment of such patients results in
irreversible structural organ damage.
Antigen presentation via HLA class I molecules is an
essential function of the mammalian adaptive immune
system. HLA class I molecules have the dual role of pre-
senting intracellular antigenic peptides to T lymphocytes
and modulating the activity of cells bearing HLA class I
binding receptors, such as natural killer cells and gamma–
delta T cells [1, 2]. Primary human immunodeWciencies
resulting from defects in the HLA class I presentation
pathway segregate into three subgroups. TAP deWciency
syndrome is the most common of these syndromes, and it is
compatible with survival into adulthood [3]. The trans-
porter associated with antigen presentation (TAP) is essen-
tial for the stabilisation and surface expression of HLA
class I molecules [4]. TAP deWciency syndrome usually
manifests itself in early childhood with chronic rhinosinus-
itis and otitis. The lower airways often get involved during
adolescence with spastic bronchitis, pneumonia and bron-
chiectasis. In addition, most patients described to date
suVered from necrotizing granulomatous skin lesions, typi-
cally appearing in adulthood [3, 5].
We present a family with two TAP-deWcient sisters, in
whom a chronic rhinosinusitis and conductive hearing
loss were the dominant clinical manifestations. We discuss
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Report of two cases
Two sisters (SAB, 31, and GAB, 40 years old at the time of
this report) in a southern Italian family have been suVering
purulent rhinosinusitis and recurrent middle ear eVusion
since early childhood. One older sister and both parents
have remained free of disease to the present day. The par-
ents were not Wrst degree cousins.
In both patients, pharyngitis and bronchitis appeared in
later childhood. In the older sister (GAB), removal of nasal
polyps during adolescence, as well as nasal septal correc-
tive surgery with infundibulotomy at the age of 20 were
carried out, but did not prevent recurrence of rhinosinusitis.
In addition, bronchiectasis and necrotizing granulomatous
skin lesions developed in the older sister during adulthood.
A sinus biopsy showed moderate chronic lymphocytic and
histiocytic inXammation in the submucosa and arterioles
and venoles surrounded by histiocytes and lymphocytes.
Necrotizing granulomatous inXammation containing multi-
nucleated giant cells and epitheloid cells were present.
Cultures, acid fast stains as well as PCR all failed to dem-
onstrate M. tuberculosis, and tuberculostatic drug treatment
had no eVect on the progression of the lesions. One year
before they presented to our clinic, both patients had been
given high-dose steroid treatment. However, symptoms
worsened in both patients, and pneumonia and bronchiecta-
sis developed in the older sister. At the Wrst presentation to
our hospital in December 2003, dried nasal mucosae with
crusts, and extensive septal perforation with near total
destruction of the lamina quadrangularis were visible in the
older sister. In the younger sister, secretion in the middle
meatus of the nose and edematous mucosa were present
with a rhinolalia. Swab cultures of the nose in both sisters
repeatedly grew Staphylococcus epidermidis and Pseudo-
monas aeuroginosa. Otoscopic Wndings showed bilateral
tympanosclerosis in both sisters. Imaging analyses, includ-
ing Magnetic Resonance of the sinuses and mastoids,
revealed chronic rhinosinusitis and mastoiditis (Fig. 1).
Hearing was immediately improved after bilateral installa-
tion of grommets. (Fig. 2). Consequently, both patients
were consistently treated with oral antibiotics according to
the results of swab cultures. In addition, daily irrigation of
the nose with saline solution and nose ointment were insti-
tuted. Under this treatment regimen, the disease has been
Fig. 1 MR imaging [left side 
SAB (a, d), right side GAB 
(b, c, e)] shows mucus retention 
in the maxillary sinuses as well 
as in the ethmoid cells 
(T1 weighted spin echo images) 
in coronal scans (a, b) and an 
anterior septal perforation (c). 
Bilateral mastoid Xuid retention 
in both sisters was observed in 
T2 weighted spin echo images 
[visible on axial scans (d, e)]123
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moderate mucosal inXammation.
Diagnosis of TAP-deWciency
TAP-deWciency syndrome is an autosomal recessive dis-
ease. Consistent with this diagnosis, tissue typing of the
two patients revealed homozygous HLA class I and class II
haplotypes (HLA-A*2601, B*4901, C*0701, DRB1*1302,
DRB3*0301, DQB1*0604, DPB1*1501) [3]. Intracellular
levels of TAP1 and TAP2 proteins were determined by
Xuorescent activated cell sorter (FACS) analysis using anti-
TAP1 and anti-TAP2 antibodies. TAP1/2 protein levels of
the two sisters were compared to the mother and an unre-
lated healthy donor. The lymphoblast cell lines T0 (TAP
competent) and T2 (TAP deWcient) and were used as posi-
tive and negative controls respectively. The results of these
experiments conWrmed markedly reduced levels of TAP 1
and 2 proteins in both patients, while the TAP1/2 protein
levels in the mother were in intermediary, consistent with a
heterozygote carrier (Fig. 3). Sequencing of the TAP 1 gene
revealed a deletion of one cytosine in exon 2, at nucleotide
Fig. 2 Bilateral tympanosclerosis (right and left ear) with consequently conductive hearing loss visible in the pure tone audiogram (SAB)
Fig. 3 Intracellular FACS 
staining of TAP1 and TAP2 
proteins in two TAP1-deWcient 
patients, their mother, an unre-
lated healthy control patient, and 
the TAP competent and 
incompetent B-lymphoblast 
lines T0 and T2 respectively. 
Mean Xuorescence intensities 
and the isotype control 
background staining are 
displayed (y-axis counts). 
Lymphocyte gated analysis 
(x-axis FL1-H)123
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premature stop codon. The mutation was conWrmed by
sequencing genomic DNA.
Discussion
TAP deWciency syndrome should be included in the diVer-
ential diagnosis of patients with early childhood onset of
purulent ENT symptoms. Granulomatous skin lesions can
appear during adolescence, as was the case in the older sis-
ter. Progressive destruction of the inner and outer nose,
chronic recurrent rhinosinusitis, mastoiditis and pharyngo-
laryngitis are also features of this syndrome. The disease
course is often complicated by recurrent bacterial bronchi-
tis and pneumonia, with development of bronchiectasis, as
was the case in the older sister. Immune suppressive ther-
apy is absolutely contraindicated and can cause severe
worsening of the disease course, e.g. progression of bron-
chiectasis and cerebral abscess per continuitatem [3, 5].
In fact, progression of chronic ENT lesions under immu-
nosuppressive treatment points to the underlying immuno-
deWciency and should call into question autoinXammatory
diagnoses such as WG [6]. Mycobacterial infection was
ruled out in both patients and tuberculostatic treatment had
no eVect on the ENT lesions. In both sisters, acute infec-
tious episodes of the upper and lower respiratory tract
responded well to antibiotics.
The diVerential diagnoses of chronic rhinosinusitis and
hearing disturbances in TAP deWciency include WG,
Churg-Strauss syndrome, systemic lupus erythematosus,
relapsing polychondritis, midline granuloma (T/NK-cell
lymphoma), polyarteritis nodosa, Cogan’s syndrome,
microscopic polyangiitis, Behcet’s syndrome and sarcoido-
sis [3, 7]. Serous otitis media results from inXammation and
irritation from nasal secretions of the oriWce of the Eusta-
chian tube. In particular, TAP deWciency should be ruled
out in patients with ANCA negative WG, childhood WG
and familial WG [3, 5].
Initial laboratory assessment in a patient with suspected
TAP deWciency syndrome should include an HLA haplo-
type and Xow cytometric (FACS) quantitation of HLA class
I cell surface expression on leukocytes. TAP deWciency is
an autosomal recessive disorder, and most patients are chil-
dren of consanguineous parents. The parents of our patients
were not Wrst degree cousins. However, the families of both
parents had been resident for generations in a small village
in southern Italy, which possibly explains the occurrence of
haplotype homozygosity in the patients. Interestingly, a
male patient from northern Italy with TAP1 deWciency with
an identical HLA haplotype and TAP1 mutation has been
previously reported [8]. The family history of this patient
revealed that his parents had previously migrated from the
same area in southern Italy as our two patients. The primary
objective of therapy for patients with TAP deWciency syn-
drome is tight control of infections in order to prevent the
development or progression of bronchiectasis and ulti-
mately respiratory failure [3]. In cases of extensive nasal
mucosal involvement in TAP deWciency syndrome, endo-
scopic sinus surgery could be performed with caution in
order not to add to the destruction potential of the disease
with resulting increase of the nasal space and crust forma-
tion. Usually, patients manage locally with various forms of
saline nasal irrigation frequently combined with a nasal
ointment to soften the crusts.
In conclusion, patients with chronic rhinosinusitis and
conductive hearing loss of unknown aetiology should be
screened for HLA class I deWciency, and in particular, for
TAP-deWciency, e.g. using the methods outlined in this arti-
cle. The treatment of choice for TAP-deWcient patients is
conservative.
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